Category/test | Prevalence by qPCR (95Â % CI) | Sensitivity (95Â % CI) | Specificity (95Â % CI) | PPV (95Â % CI) | NPV (95Â % CI) | Infections missed (per 1000 women) |
---|---|---|---|---|---|---|
P. falciparum | ||||||
 Overall | ||||||
  RDT | 14.7 (12.7, 16.9) | 45.6 (38.0, 53.4)** | 96.4 (95.0, 97.4) | 68.4 (59.1, 76.8) | 91.1 (89.2, 92.8) | 93 of 171 (54.4 %) |
  LM | 63.7 (56.1, 70.9)** | 97.6 (96.4, 98.4) | 82.0 (74.4, 88.1) | 94.0 (92.3, 95.4) | 62 of 171 (36.3 %) | |
 Anaemia only (n = 854) | ||||||
  RDT | 10.1 (8.1, 12.3) | 18.6 (11.0, 28.4)** | 98.4 (97.3, 99.2) | 57.1 (37.2, 75.5) | 91.5 (89.4, 93.3) | 70 of 86 (81.4 %) |
  LM | 45.3 (34.6, 56.5)** | 98.8 (97.8, 99.5) | 81.3 (67.4, 91.1) | 94.2 (92.3, 95.7) | 47 of 86 (54.7 %) | |
 Symptomatic (n = 308) | ||||||
  RDT | 27.6 (22.6, 32.6) | 72.9 (62.2, 82.0) | 89.2 (84.4, 93.0)* | 72.1 (61.4, 81.2) | 89.6 (84.9, 93.3) | 23 of 85 (27.1 %) |
  LM | 82.4 (72.6, 89.8) | 93.3 (89.1, 96.2)* | 82.4 (72.6, 89.8) | 93.3 (89.1, 96.2) | 15 of 85 (17.6 %) | |
P. vivax | ||||||
 RDT | 2.2 (1.3, 3.2) | 12.0 (2.6, 31.5) | – | – | – | 22 of 25 (88.0 %) |
 LM | 24.0 (9.4, 45.1) | – | – | – | 19 of 25 (76.0 %) |